Cortagen Dosage, half-life & reference guide

Also known as Ala-Glu-Asp-Pro · AEDP peptide · Cortagene

Reviewed Evidence: EmergingPublished by PepVault

A four-amino-acid peptide from the Russian bioregulator program, designed from the brain-cortex drug Cortexin. In rats it sped the regrowth of an injured nerve and the recovery from poor blood flow to the brain, and in lab cells it changed which genes were active. No human study has been published.

How often
Daily
Half-life
Unknown
Evidence
●●● Emerging
Route
SubQ injection

No human study has tested a dose of Cortagen: the amounts people run are their own protocol, not a reference.

How it works.

A tetrapeptide, Ala-Glu-Asp-Pro (AEDP), that Vladimir Khavinson's St. Petersburg group designed from the amino acids of Cortexin, their peptide drug made from brain cortex. In rats with a cut and stitched sciatic nerve, the regrowing fibers grew 27% faster and carried signals 40% faster; in rats with chronic poor blood flow to the brain, a separate St. Petersburg group found it sped the recovery of behavior and limited oxidative damage, as Cortexin did. In mouse hearts it changed the activity of about a hundred genes, and in blood cells from people aged 75 to 88, grown in the lab, it loosened tightly packed chromatin. No human study of Cortagen is indexed on PubMed.

Commonly reported: Little to feel during a course, and now and then a light headache; user reports are few.

A smiling woman in a cream top at a wooden desk by a window with a notebook, a mug and her phone

PepVault for iPhone

Track cortagen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Where Cortagen works.

A body with Brain, nerves & sleep lit
  • Brain, nerves & sleep

    In animals. In rats it sped the regrowth of an injured nerve and the recovery from poor blood flow to the brain.

An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

Week by week.

What to expect in the first 8 weeks

Onset
Not established (no human data)
Peak effect
Not established
Duration
Courses of 10–20 days (community practice)
  1. Day 1–10Community

    Early days of a course

    Cortagen has no human studies, so what people describe is all there is. Commonly reported: little to feel, and now and then a light headache or some discomfort where it goes in. User reports are few.

    Updated Nov 2026

  2. Day 10–30Animal

    Where the nerve result comes from

    Cortagen's best-known finding is in rats: after a nerve was cut and stitched, ten days of it made the regrowing fibers grow and conduct faster. No study has tested that in people.

    The science

    Turchaninova 2000: intramuscular Cortagen for 10 days after transection and suture of the rat sciatic nerve raised the growth rate of regenerating fibers by 27% and their conduction velocity by 40%. Kolosova 2002 reported a delayed effect on the restoration of injured nerve function (no abstract on PubMed).

    Sources
    • Turchaninova et al. (2000)
    • Kolosova et al. (2002)

    Updated Nov 2026

  3. Any dayAnimal

    What Cortagen is built on

    A four-amino-acid peptide designed from the Russian brain-cortex drug Cortexin. In rats it helped injured nerves regrow and brains recover from poor blood flow; in mice and human cells in the lab it changed which genes were active. There is no human study.

    The science

    Anisimov 2004: Cortagen (Ala-Glu-Asp-Pro) was designed from the amino-acid analysis of Cortexin; in CBA mice given it for 5 days, 234 heart clones (1.53%) changed expression, matching 110 known genes. Zarubina 2011 (a St. Petersburg pharmacology group): in rats with chronic brain ischemia, Cortexin and Cortagen sped the recovery of behavior and prevented excess lipid peroxidation. Kozina 2007: in rats it lowered lipid peroxidation products. Khavinson 2004: in leukocytes of people aged 75–88 it decondensed chromatin.

    Sources
    • Anisimov et al. (2004)
    • Turchaninova et al. (2000)
    • Zarubina & Shabanov (2011)
    • Kozina (2007)
    • Khavinson et al. (2004)

    Updated Nov 2026

  4. With PinealonCommunity

    The two brain peptides

    Cortagen and Pinealon are the bioregulator program's two brain peptides, and people often run them together; Epitalon commonly joins them. No study has tested them together.

    The science

    Pinealon (Glu-Asp-Arg) and Cortagen (Ala-Glu-Asp-Pro) are both brain peptides of the program (Khavinson 2021 review; Anisimov 2004). The combination is community and protocol practice, without a study.

    Sources
    • Khavinson et al. (2021)
    • Anisimov et al. (2004)

    Updated Nov 2026

Day 1 is the day you start it.

No human study of Cortagen has been published. The mechanism and the effects come from rat and mouse studies and lab work on human cells, most of it by its developers.

Preliminary research

A typical run.

Run notes

Cycle
Run in short courses rather than continuously, like the other bioregulators: community courses run about 10–20 days, a few times a year. In the rat nerve study it was given for 10 days after the injury. No study in people has tested a course length.Community practice — opinions vary. Not a clinical recommendation.
Timing
No timing has been studied.
Route
SubQ injection
Stacks
Pinealon, Epitalon

Track it in the app

Safety.

Common side effects

  • Injection-site discomfort
  • Occasional headache

Interactions

No interaction studies exist, including with Pinealon, Epitalon or Cortexin, the peptides it is most often run beside.

Safety notes

No safety study exists: no human study of Cortagen is indexed, so its side effects are known only from user reports, and nothing is known about long-term use. Discuss with your clinician before use, particularly during pregnancy or breastfeeding, or with a neurological condition.

Compared with.

Questions people ask.

What is Cortagen?

A four-amino-acid peptide from the Russian bioregulator program, designed from the brain-cortex drug Cortexin. In rats it sped the regrowth of an injured nerve and the recovery from poor blood flow to the brain, and in lab cells it changed which genes were active. No human study has been published.

How is Cortagen dosed in research?

The library carries no reference dose for Cortagen. No human study has tested a dose of Cortagen: the amounts people run are their own protocol, not a reference.

How long does Cortagen last?

The half-life of Cortagen is unknown (never measured).

What do people report on Cortagen?

Commonly reported on Cortagen: little to feel during a course, and now and then a light headache; user reports are few.

Is Cortagen safe?

The research basis for Cortagen is emerging: primarily preclinical / limited human data. Common side effects in the library: injection-site discomfort and occasional headache.

What does Cortagen stack with?

Common stacks for Cortagen: Pinealon and Epitalon.

Track it in the app

Research.

The literature

Search the latest research

Reference.

Cadence

Daily

Half-life

Unknown

Unknown (never measured)

Research basis

●●● Emerging

Primarily preclinical / limited human data

PepVault for iPhone

Track cortagen in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo

Reviewed How we check the library